The role of circulating MiR-34a-5p and MiR-let7a-5p as a diagnostic tumor markers in breast cancer a cross-sectional analysis
Molecular Biology Reports · 2026-12 · 53 (1)
DOI: 10.1007/s11033-026-12166-2 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Molecular Biology Reports, online erschienen am 19.06.2026. Verfasst von Ruwaidah A R Abbas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathological Analysis, College of Applied Science, University of Fallujah, Fallujah, Iraq. Hauptthemen laut MEDLINE: MicroRNAs, Cell-Free Nucleic Acids, Biomarkers, Tumor, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Breast cancer (BC) remains a leading cause of malignancy-related deaths in women. underscoring the need for low-cost, fast, sensitive and non-invasive biomarkers. MicroRNAs as a critical regulators of gene expression, with distinct expression profiles linked to tumor genesis. Particularly miR-let7a-5p and miR-34a-5p are circulating molecules with key roles in tumor suppression and proliferation, offering significant diagnostic potential. OBJECTIVES: This exploratory study investigated the expression levels of circulating miRNAs in breast cancer patients and healthy groups and assessed their potential utility as non-invasive diagnostic biomarkers for breast cancer. METHODS: 200 serum samples were used in this analysis, the amount of each miR expression was measured using RT-qPCR and the fold changes were determined by 2^-ΔΔCt. P-values were determined by the t-test. ROC analysis demonstrated significant diagnostic accuracy to identify BC patients. RESULTS: Our findings indicate that circulating miR-34a-5p and miR-let-7a-5p are significant non-invasive breast cancer biomarkers, both being notably down-regulated in BC patients compared to healthy controls. With lower expression (fold change 0.503 vs. 0.810), superior diagnostic accuracy (AUC 0.8232) and higher (sensitivity 84%), miR-34a-5p outperformed let-7a-5p. No statistically significant association was identified between the studied miRNAs and age, BMI, or ER expression; however, miR-34a-5p demonstrated a weak negative correlation with PR. CONCLUSION: Both circulating miR-34a-5p and let-7a-5p are significantly down-regulated in BC patients. MiR-34a-5p showed better accuracy on diagnostic performance, indicating its possible value as a promising non-invasive biomarker for the detection of breast cancer. This study explores the potential of these miRs in developing cost-effective strategies for breast cancer detection and risk assessment, monitoring and classification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathological Analysis, College of Applied Science, University of Fallujah, Fallujah, Iraq.
- Trust Doctor, Liverpool University Hospital NHS Foundation Trust, MSc/kings college London, Liverpool, UK.
- Iraqi Center for Cancer Research and Medical Genetics, Al-Mustansiriya University, Baghdad, Iraq.
- Department of biology, College of Science for Women, University of Baghdad, Baghdad, Iraq. sana.habib@csw.uobaghdad.edu.iq.
ORCID-Profile: Sana Mh Al-Shimmary
Zitieren
APA
Abbas, R. A. R., Abbas, R. A. R., Mohammed, S. S., & Al-Shimmary, S. M. (2026). The role of circulating MiR-34a-5p and MiR-let7a-5p as a diagnostic tumor markers in breast cancer a cross-sectional analysis. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-12166-2
Vancouver
Abbas RAR, Abbas RAR, Mohammed SS, Al-Shimmary SM. The role of circulating MiR-34a-5p and MiR-let7a-5p as a diagnostic tumor markers in breast cancer a cross-sectional analysis. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-12166-2
BibTeX
@article{Abbas2026,
author = {Abbas, Ruwaidah A R and Abbas, Rounaq A R and Mohammed, Sally S and Al-Shimmary, Sana Mh},
title = {The role of circulating MiR-34a-5p and MiR-let7a-5p as a diagnostic tumor markers in breast cancer a cross-sectional analysis},
journal = {Molecular Biology Reports},
year = {2026},
volume = {53},
number = {1},
doi = {10.1007/s11033-026-12166-2}
}
EUVIMED